Works by Lincoff, A. Michael


Results: 94
    1
    2
    3
    4
    5

    Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door‐to‐balloon time.

    Published in:
    Catheterization & Cardiovascular Interventions, 2020, v. 96, n. 2, p. E165, doi. 10.1002/ccd.28785
    By:
    • Huded, Chetan P.;
    • Kapadia, Samir R.;
    • Ballout, Jad A.;
    • Krishnaswamy, Amar;
    • Ellis, Stephen G.;
    • Raymond, Russell;
    • Cho, Leslie;
    • Simpfendorfer, Conrad;
    • Bajzer, Chris;
    • Martin, Joseph;
    • Nair, Ravi;
    • Lincoff, A. Michael;
    • Kravitz, Kathleen;
    • Menon, Venu;
    • Hantz, Scott;
    • Khot, Umesh N.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2003, v. 289, n. 7, p. 853, doi. 10.1001/jama.289.7.853
    By:
    • Lincoff, A. Michael;
    • Bittl, John A.;
    • Harrington, Robert A.;
    • Feit, Frederick;
    • Kleiman, Neal S.;
    • Jackman, J. Daniel;
    • Sarembock, Ian J.;
    • Cohen, David J.;
    • Spriggs, Douglas;
    • Ebrahimi, Ramin;
    • Keren, Gadi;
    • Carr, Jeffrey;
    • Cohen, Eric A.;
    • Betriu, Amadeo;
    • Desmet, Walter;
    • Kereiakes, Dean J.;
    • Rutsch, Wolfgang;
    • Wilcox, Robert G.;
    • de Feyter, Pim J.
    Publication type:
    Article
    12

    Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction: GUSTO V Randomized Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2002, v. 288, n. 17, p. 2130, doi. 10.1001/jama.288.17.2130
    By:
    • Lincoff, A. Michael;
    • Califf, Robert M.;
    • Van de Werf, Frans;
    • Willerson, James T.;
    • White, Harvey D.;
    • Armstrong, Paul W.;
    • Guetta, Victor;
    • Gibler, W. Brian;
    • Hochman, Judith S.;
    • Bode, Christoph;
    • Vahanian, Alec;
    • Steg, P. Gabriel;
    • Ardissino, Diego;
    • Savonitto, Stefano;
    • Bar, Frits;
    • Sadowski, Zygmunt;
    • Betriu, Amadeo;
    • Booth, Joan E.;
    • Wolski, Kathy;
    • Waller, Michael
    Publication type:
    Article
    13
    14

    Stent scrutiny.

    Published in:
    2000
    By:
    • Lincoff, Michael;
    • Lincoff, A M
    Publication type:
    commentary
    15

    Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277706
    By:
    • Grobbee, Esmée J.;
    • de Jong, Vivian D.;
    • Schrieks, Ilse C.;
    • Tushuizen, Maarten E.;
    • Holleboom, Adriaan G.;
    • Tardif, Jean-Claude;
    • Lincoff, A. Michael;
    • Schwartz, Gregory G.;
    • Castro Cabezas, Manuel;
    • Grobbee, Diederick E.
    Publication type:
    Article
    16

    Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.

    Published in:
    European Heart Journal, 2016, v. 37, n. 4, p. 390, doi. 10.1093/eurheartj/ehv443
    By:
    • Udell, Jacob A.;
    • Bonaca, Marc P.;
    • Collet, Jean-Philippe;
    • Lincoff, A. Michael;
    • Kereiakes, Dean J.;
    • Costa, Francesco;
    • Cheol Whan Lee;
    • Mauri, Laura;
    • Valgimigli, Marco;
    • Seung-Jung Park;
    • Montalescot, Gilles;
    • Sabatine, Marc S.;
    • Braunwald, Eugene;
    • Bhatt, Deepak L.
    Publication type:
    Article
    17

    Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 37, p. 2516, doi. 10.1093/eurheartj/ehu177
    By:
    • Lincoff, A. Michael;
    • Roe, Matthew;
    • Aylward, Philip;
    • Galla, John;
    • Rynkiewicz, Andrzej;
    • Guetta, Victor;
    • Zelizko, Michael;
    • Kleiman, Neal;
    • White, Harvey;
    • McErlean, Ellen;
    • Erlinge, David;
    • Laine, Mika;
    • dos Santos Ferreira, Jorge Manuel;
    • Goodman, Shaun;
    • Mehta, Shamir;
    • Atar, Dan;
    • Suryapranata, Harry;
    • Jensen, Svend Eggert;
    • Forster, Tamas;
    • Fernandez-Ortiz, Antonio
    Publication type:
    Article
    18

    The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.

    Published in:
    European Heart Journal, 2012, v. 33, n. 17, p. 2143
    By:
    • Bhatt, Deepak L.;
    • Paré, Guillaume;
    • Eikelboom, John W.;
    • Simonsen, Katy L.;
    • Emison, Eileen S.;
    • Fox, Keith A.A.;
    • Steg, Ph. Gabriel;
    • Montalescot, Gilles;
    • Bhakta, Nihar;
    • Hacke, Werner;
    • Flather, Marcus D.;
    • Mak, Koon-Hou;
    • Cacoub, Patrice;
    • Creager, Mark A.;
    • Berger, Peter B.;
    • Steinhubl, Steven R.;
    • Murugesan, Gurunathan;
    • Mehta, Shamir R.;
    • Kottke-Marchant, Kandice;
    • Lincoff, A. Michael
    Publication type:
    Article
    19

    Restenosis-an open file.

    Published in:
    Clinical Cardiology, 1996, v. 19, n. 5, p. 347, doi. 10.1002/clc.4960190505
    By:
    • Gottsauner-Wolf, Michael;
    • Moliterno, David J.;
    • Michael Lincoff, A.;
    • Topol, Eric J.
    Publication type:
    Article
    20

    Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.

    Published in:
    European Heart Journal, 2024, v. 45, n. 47, p. 5023, doi. 10.1093/eurheartj/ehae614
    By:
    • Gibson, C Michael;
    • Duffy, Danielle;
    • Bahit, Maria Cecilia;
    • Chi, Gerald;
    • White, Harvey;
    • Korjian, Serge;
    • Alexander, John H;
    • Lincoff, A Michael;
    • Heise, Mark;
    • Kingwell, Bronwyn A;
    • Nicolau, Jose C;
    • Lopes, Renato D;
    • Cornel, Jan H;
    • Lewis, Basil S;
    • Vinereanu, Dragos;
    • Goodman, Shaun G;
    • Bode, Christoph;
    • Steg, Ph Gabriel;
    • Libby, Peter;
    • Sacks, Frank M
    Publication type:
    Article
    21
    22

    Semaglutide and Cardiovascular Outcomes by Baseline HbA<sub>1c</sub> and Change in HbA<sub>1c</sub> in People With Overweight or Obesity but Without Diabetes in SELECT.

    Published in:
    Diabetes Care, 2024, v. 47, n. 8, p. 1360, doi. 10.2337/dc24-0764
    By:
    • Lingvay, Ildiko;
    • Deanfield, John;
    • Kahn, Steven E.;
    • Weeke, Peter E.;
    • Toplak, Hermann;
    • Scirica, Benjamin M.;
    • Rydén, Lars;
    • Rathor, Naveen;
    • Plutzky, Jorge;
    • Morales, Cristobal;
    • Lincoff, A. Michael;
    • Lehrke, Michael;
    • Jeppesen, Ole Kleist;
    • Gajos, Grzegorz;
    • Colhoun, Helen M.;
    • Cariou, Bertrand;
    • Ryan, Donna
    Publication type:
    Article
    23

    Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

    Published in:
    Diabetes Care, 2024, v. 47, n. 8, p. 1350, doi. 10.2337/dc24-0491
    By:
    • Kahn, Steven E.;
    • Deanfield, John E.;
    • Jeppesen, Ole Kleist;
    • Emerson, Scott S.;
    • Boesgaard, Trine Welløv;
    • Colhoun, Helen M.;
    • Kushner, Robert F.;
    • Lingvay, Ildiko;
    • Burguera, Bartolome;
    • Gajos, Grzegorz;
    • Horn, Deborah Bade;
    • Hramiak, Irene M.;
    • Jastreboff, Ania M.;
    • Kokkinos, Alexander;
    • Maeng, Michael;
    • Matos, Ana Laura S.A.;
    • Tinahones, Francisco J.;
    • Lincoff, A. Michael;
    • Ryan, Donna H.
    Publication type:
    Article
    24
    25
    26
    27
    28

    Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.

    Published in:
    Obesity (19307381), 2025, v. 33, n. 3, p. 452, doi. 10.1002/oby.24222
    By:
    • Kushner, Robert F.;
    • Ryan, Donna H.;
    • Deanfield, John;
    • Kokkinos, Alexander;
    • Cercato, Cintia;
    • Wilding, John;
    • Burguera, Bartolome;
    • Wu, Chau‐Chung;
    • Craciun, Anca‐Elena;
    • Pall, Denes;
    • Hramiak, Irene;
    • Hjelmesæth, Jøran;
    • Harder‐Lauridsen, Nina M.;
    • Weimers, Petra;
    • Jeppesen, Ole Kleist;
    • Kallenbach, Klaus;
    • Lincoff, A. Michael;
    • Lingvay, Ildiko
    Publication type:
    Article
    29

    Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.

    Published in:
    Obesity (19307381), 2023, v. 31, n. 1, p. 111, doi. 10.1002/oby.23621
    By:
    • Lingvay, Ildiko;
    • Brown‐Frandsen, Kirstine;
    • Colhoun, Helen M.;
    • Deanfield, John;
    • Emerson, Scott S.;
    • Esbjerg, Sille;
    • Hardt‐Lindberg, Søren;
    • Hovingh, G. Kees;
    • Kahn, Steven E.;
    • Kushner, Robert F.;
    • Lincoff, A. Michael;
    • Marso, Steven P.;
    • Fries, Tea Monk;
    • Plutzky, Jorge;
    • Ryan, Donna H.
    Publication type:
    Article
    30
    31
    32
    33

    Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 13, p. 1561, doi. 10.1001/jama.299.13.1561
    By:
    • Nissen, Steven E.;
    • Nicholls, Stephen J.;
    • Wolski, Kathy;
    • Nesto, Richard;
    • Kupfer, Stuart;
    • Perez, Alfonso;
    • Jure, Horacio;
    • De Larochellière, Robert;
    • Staniloae, Cezar S.;
    • Mavromatis, Kreton;
    • Saw, Jacqueline;
    • Hu, Bo;
    • Lincoff, A. Michael;
    • Tuzcu, E. Murat
    Publication type:
    Article
    34

    Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 13, p. 1547, doi. 10.1001/jama.299.13.1547
    By:
    • Nissen, Steven E.;
    • Nicholls, Stephen J.;
    • Wolski, Kathy;
    • Rodés-Cabau, Josep;
    • Cannon, Christopher P.;
    • Deanfield, John E.;
    • Després, Jean-Pierre;
    • Kastelein, John J.P.;
    • Steinhubl, Steven R.;
    • Kapadia, Samir;
    • Yasin, Muhammad;
    • Ruzyllo, Witold;
    • Gaudin, Chrisophe;
    • Job, Bernard;
    • Hu, Bo;
    • Bhatt, Deepak L.;
    • Lincoff, A. Michael;
    • Tuzcu, E. Murat
    Publication type:
    Article
    35

    Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management.

    Published in:
    JAMA: Journal of the American Medical Association, 2007, v. 298, n. 21, p. 2497, doi. 10.1001/jama.298.21.2497
    By:
    • Stone, Gregg W.;
    • Ware, James H.;
    • Bertrand, Michael E.;
    • Lincoff, A. Michael;
    • Moses, Jeffrey W.;
    • Ohman, E. Magnus;
    • White, Harvey D.;
    • Feit, Frederick;
    • Colombo, Antonio;
    • McLaurin, Brent T.;
    • Cox, David A.;
    • Manoukian, Steven V.;
    • Fahy, Martin;
    • Clayton, Tim C.;
    • Mehran, Roxana;
    • Pocock, Stuart J.
    Publication type:
    Article
    36
    37
    38

    Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein llb/llla Inhibitors in Acute Coronary Syndromes.

    Published in:
    JAMA: Journal of the American Medical Association, 2007, v. 297, n. 6, p. 591, doi. 10.1001/jama.297.6.591
    By:
    • Stone, Gregg W.;
    • Bertrand, Michel E.;
    • Moses, Jeffrey W.;
    • Ohman, E. Magnus;
    • Lincoff, A. Michael;
    • Ware, James H.;
    • Pocock, Stuart J.;
    • McLaurin, Brent T.;
    • Cox, David A.;
    • Jafar, M. Zubair;
    • Chandna, Harish;
    • Hartmann, Fraz;
    • Leisch, Franz;
    • Strasser, Ruth H.;
    • Desaga, Martin;
    • Stuckey, Thomas D.;
    • Zelman, Richard B.;
    • Lieber, Ira H.;
    • Cohen, David J.;
    • Mehran, Roxana
    Publication type:
    Article
    39

    Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2004, v. 292, n. 6, p. 696, doi. 10.1001/jama.292.6.696
    By:
    • Lincoff, A. Michael;
    • Kleiman, Neal S.;
    • Kereiakes, Dean J.;
    • Feit, Frederick;
    • Bittl, John A.;
    • Jackman, J. Daniel;
    • Sarembock, Ian J.;
    • Cohen, David J.;
    • Spriggs, Douglas;
    • Ebrahimi, Ramin;
    • Keren, Gadi;
    • Carr, Jeffrey;
    • Cohen, Eric A.;
    • Betriu, Amadeo;
    • Desmet, Walter;
    • Rutsch, Wolfgang;
    • Wilcox, Robert G.;
    • de Feyter, Pim J.;
    • Vahanian, Alec;
    • Topol, Eric J.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.

    Published in:
    European Heart Journal, 2005, v. 26, n. 2, p. 128, doi. 10.1093/eurheartj/ehi061
    By:
    • Labinaz, Marino;
    • Mathias, Jasmine;
    • Pieper, Karen;
    • Granger, Christopher B.;
    • Lincoff, A. Michael;
    • Moliterno, David J.;
    • Van de Werf, Frans;
    • Simes, John;
    • White, Harvey D.;
    • Simoons, Maarten L.;
    • Califf, Robert M.;
    • Topol, Eric J.;
    • Armstrong, Paul W.;
    • Harrington, Robert A.
    Publication type:
    Article
    47

    Impact of anticoagulation regimen prior to revascularization in patients with non- ST-segment elevation acute coronary syndromes: The ACUITY trial.

    Published in:
    Catheterization & Cardiovascular Interventions, 2016, v. 88, n. 2, p. 174, doi. 10.1002/ccd.26232
    By:
    • Geisler, Tobias;
    • Droppa, Michal;
    • Gawaz, Meinrad;
    • Steinhubl, Steven R.;
    • Bertrand, Michel E.;
    • Lincoff, A. Michael;
    • Cequier, Angel R.;
    • Desmet, Walter;
    • Rasmussen, Lars H.;
    • Hoekstra, James W.;
    • Bernstein, Debra;
    • Deliargyris, Efthymios N.;
    • Mehran, Roxana;
    • Stone, Gregg W.
    Publication type:
    Article
    48

    Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.

    Published in:
    Catheterization & Cardiovascular Interventions, 2016, v. 87, n. 3, p. 391, doi. 10.1002/ccd.26146
    By:
    • Yu, Jennifer;
    • Mehran, Roxana;
    • Clayton, Tim;
    • Gibson, C. Michael;
    • Brodie, Bruce R.;
    • Witzenbichler, Bernhard;
    • Lincoff, A. Michael;
    • Deliargyris, Efthymios N.;
    • Gersh, Bernard J.;
    • Pocock, Stuart J.;
    • Stone, Gregg W.;
    • Dangas, George D.
    Publication type:
    Article
    49

    Percutaneous coronary revascularization in coronary artery disease: Lessons from a single center experience.

    Published in:
    Catheterization & Cardiovascular Interventions, 2013, v. 81, n. 1, p. E1, doi. 10.1002/ccd.24442
    By:
    • Aksoy, Olcay;
    • Tuzcu, E. Murat;
    • Ellis, Stephen G.;
    • Whitlow, Patrick L.;
    • Cam, Akin;
    • Batizy, Lillian;
    • Agarwal, Shikhar;
    • Franco, Irving;
    • Bajzer, Christopher;
    • Simpfendorfer, Conrad;
    • Raymond, Russell;
    • Nair, Ravi;
    • Cho, Leslie;
    • Shishehbor, Mehdi H.;
    • Lincoff, A. Michael;
    • Kapadia, Samir R.
    Publication type:
    Article
    50